Inogen, Inc. (INGN) Stock
Inogen stock price chart
INGN stock quote & key statistics
Inogen annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $348.7M | -$22.7M | -$0.61 |
| FY2024 | $335.7M | -$35.9M | -$0.87 |
| FY2023 | $315.7M | -$102.4M | -$2.68 |
| FY2022 | $377.2M | -$83.8M | -$1.39 |
| FY2021 | $358.0M | -$6.3M | -$0.29 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Inogen, Inc.
Inogen, Inc., a prominent medical technology enterprise based in Goleta, California, specializes in the development, manufacturing, and global distribution of portable oxygen concentrators. These innovative devices are crucial for delivering long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen's product lineup includes the renowned Inogen One, a portable concentrator that efficiently concentrates air to provide a reliable source of supplemental oxygen wherever patients may need it. Additionally, the company offers the Inogen At Home line of stationary oxygen concentrators, catering to diverse patient needs with advanced respiratory support solutions.
Beyond its core products, Inogen, Inc. also provides Inogen Tidal Assist Ventilators and a comprehensive range of related accessories, ensuring comprehensive respiratory care for patients worldwide. Notably, the company supports patient access through direct rentals of its devices, enhancing affordability and accessibility to its innovative healthcare solutions.
Established in 2001, Inogen, Inc. has grown into a leading player in the medical device industry, recognized for its commitment to improving the quality of life for individuals with respiratory challenges. Headquartered in California's vibrant healthcare and technology hub, the company benefits from a robust ecosystem of innovation and collaboration, driving its continuous development of cutting-edge oxygen therapy solutions.
With a steadfast dedication to advancing respiratory health and patient comfort, Inogen, Inc. continues to expand its global presence while maintaining a strong focus on innovation, quality, and customer satisfaction in the evolving healthcare landscape.
Inogen stock FAQ
What is the Inogen stock ticker symbol?
Inogen, Inc. trades on the NASDAQ under the ticker symbol INGN.
What sector and industry is Inogen in?
Inogen, Inc. is classified in the Healthcare sector, Medical Devices industry.
How many employees does Inogen have?
Inogen, Inc. has about 753 full-time employees.
What were Inogen's revenue and earnings last fiscal year?
Inogen reported revenue of $348.7M and net income of -$22.7M in fiscal 2025, with earnings per share of -$0.61. Revenue grew 3.9% from the prior year.
Is Inogen in the Russell 2000?
Yes. Inogen, Inc. (INGN) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Inogen go public?
Inogen stock began trading on February 14, 2014.
Russell 2000 Medical Devices stocks
All Russell 2000 →- AORTArtivion
- ATECAlphatec
- AXGNAxoGen
- BFLYButterfly Network
- CNMDCONMED
- ENOVEnovis
- ESTAEstablishment Labs
- GKOSGlaukos
- HAEHaemonetics
- IARTIntegra LifeSciences
- INSPInspire Medical Systems
- IRTCiRhythm
- ITGRInteger
- LIVNLivaNova
- NEOGNeogen
- NVCRNovoCure
- PRCTPROCEPT BioRobotics
- QDELQuidelOrtho
- SIBNSI-BONE
- TMDXTransMedics
- TNDMTandem Diabetes Care
- TXG10x Genomics
- UFPTUFP Technologies
- VREXVarex Imaging